[1] Pal SN,Kofidis T.New cell therapies in cardiology[J].Expert Rev Cardiovasc Ther,2012,10(8):1023-1037.[2] Emdin M,Vittorini S,Passino C.Old and new biomarkers of heart failure[J].Eur J Heart Fail,2009,11(4):331-335.[3] Eurlings LW,Sanders-van Wijk S,van Kimmenade R,et al.multimarker strategy for short-term risk assessment in patients with dyspnea in the Emergency Department[J].Am Coll Cardiol,2012,60(17):1668-1677.[4] 施 冰,冬 兰,尹秋生,等.半乳糖凝集素3在老年收缩功能正常心力衰竭患者中的临床价值[J].中华老年心脑血管病杂志,2014,16(1):12-14.[5] Bayes-Genis A,de Antonio M,Vila J,et al.Head-to-Head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification[J].J Am Coll of Cardiol,2014,63(2):158-166.[6] 张育民,李庆宽,全 勇,等.半乳糖凝集素-3对慢性心力衰竭的诊断价值[J].中国医师杂志,2013,15(11):1446-1449.[7] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):P98-122.[8] Felker GM,Fiuzat M,Shaw LK,et al.Galectin-3 in ambulatory patients with heart failure:results from the HF-ACTION study[J].Circ Heart Fail,2012,5(1):72-78.[9] Tang WH,Shrestha K,Shao Z,et al.Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival[J].Am J Cardiol,2011,108(3):385-390.[10] Lok DJ,Klip IT,Lok SI,et al.Incremental prognostic nower of Novel biomarkers (growth-differentiation factor-15,high-sensitivity C-reactive protein,galectin-3,and high-sensitivity troponin-T) in patients with advanced chronic heart failure[J].Am J Cardiol,2013,112(6):831-837.[11] Ueland T,Aukrust P,Broch K,et al.Galectin-3 in heart failure:high levels are associated with all-cause mortality[J].Int J Cardiol,2011,150(3):361-364.[12] Van der Velde AG,Gullestad L,Ueland T,et al.prognostic value of changes in galectin-3 levels over time in patients with heart failure:Data from CORONA and COACH[J].Circ Heart Fail,2013,6(2):219-226.[13] Gullestad L,Ueland T,Kjekshus J,et al.The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)[J].Am Heart J,2012,164(6):878-883.[14] de Boer RA,Lok DJ,Jaarsma T,et al.Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction[J].Ann Med,2011,43(1):60-68.[15] Carrasco-Sánchez FJ, Aramburu-Bodas O, Salamanca-Bautista P,et al.Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction[J].Int J Cardioly,2013,169(3):177-182.[16] Anand IS,Rector TS,Kuskowski M,et al.Baseline and serial measurements of galectin-3 in patients with heart failure:relationship to prognosis and effect of treatment with valsartan in the Val-HeFT[J].Eur J of Heart Fail,2013,15(5):511-518.[17] LokDJ,Van Der Meer P,dela Porte PW,et al.Prognostic value of galectin-3,a novel marker of fibrosis,in patients with chronic heart failure:data from the DEAL-HF study[J].Clini Res Cardiol,2010,99(55):323-328.[18] Battistoni A,Rubattu S,Volpe M,et al.Circulating biomarkers with preventive,diagnostic and prognostic implications in cardiovascular diseases[J].Int J Cardiol, 157(2):160-168.[19] Böhm M,Voors AA,Ketelslegers JM,et al.Biomarkers:optimizing treatment guidance in heart failure[J].Clini Res Cardiol,2011,100(11):973-981.[20] 周 恒,唐其柱,代 佳,等.血清半乳糖凝集素-3 水平与慢性心力衰竭患者预后关系的 Meta 分析[J].中华临床医师杂志,2013,7(23): 10809-10813. |